PRVB

Provention Bio, Inc.

NASDAQ

Add Alert

PRVB

Provention Bio, Inc.

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Newer

north40000 PremiumMember

05/28/21 9:04 PM

Post #33

Pdufa date is early June(?).

StonkmasterDuck Free

05/28/21 8:47 PM

Post #32

Re: #27: @sokol - FDA Advisory Committee Votes in Favor of the

Puts are up over 80% now, would hate to be a shareholder of any bio tech run by Ashleigh Palmer

beambe

05/28/21 3:22 PM

Post #31

Re: #30: @beambe - Goo $ 4

or $ 2

beambe

05/28/21 3:18 PM

Post #30

Goo $ 4

Roadtojourney Free

05/28/21 9:08 AM

Post #29

Wow look at the meme stock and then there is this even if such a good news?? Makes no sense imo

StonkmasterDuck Free

05/27/21 10:18 PM

Post #28

Re: #26: @StonkmasterDuck - Short this bio pos ITM puts all the way

Not concerned, did my research into the company.

sokol

05/27/21 10:17 PM

Post #27

Re: #26: @StonkmasterDuck - Short this bio pos ITM puts all the way

FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D)

StonkmasterDuck Free

05/25/21 5:03 PM

Post #26

Short this bio pos ITM puts all the way

ClayTrader Free

05/25/21 4:59 PM

Post #25

* * $PRVB Video Chart 05-25-2021 * *

Link to Video - click here to watch the technical chart video

beambe

05/25/21 1:48 PM

Post #24

Volume

ClayTrader Free

04/09/21 4:54 PM

Post #23

* * $PRVB Video Chart 04-09-2021 * *

Link to Video - click here to watch the technical chart video

jerseyboy

01/23/21 11:43 PM

Post #22

Re: #21: @jerseyboy - Nice news today - this is going to

This now trades below what the recently-announced offering price is. That, to me, seems idiotic given the obvious value of this company and the quality of its prospects.

jerseyboy

12/21/20 5:45 PM

Post #21

Re: #20: @jerseyboy - I love this stock - I see very

Nice news today - this is going to be a very successful company in the not-too-distant future.

jerseyboy

12/12/20 10:34 AM

Post #20

Re: #19: @jerseyboy -

I love this stock - I see very good things happening to the share price within the next year.

jerseyboy

12/05/20 9:02 PM

Post #19

Re: #18: @Cgfarmaceuticals - Looking good around here!

Cgfarmaceuticals Free

12/04/19 9:33 PM

Post #18

Looking good around here!

ClayTrader Free

11/06/19 5:09 PM

Post #17

* * $PRVB Video Chart 11-06-19 * *

Link to Video - click here to watch the technical chart video

quito_yume Free

09/30/19 1:20 PM

Post #16

It's a good price right now if you happen to be paying attention

UNDAUNTED

07/15/19 9:42 AM

Post #15

Re: #14: @UNDAUNTED - We got a pop this morning...up over 5%

Up over 10% @ 13.21. Vol = 105k

UNDAUNTED

07/15/19 9:35 AM

Post #14

We got a pop this morning...up over 5% @ 9:34. Vol = 54k

derkampfer Free

06/18/19 10:58 PM

Post #13

Even more insider buying reported today after bell. Add to that 3x increase in price targets announced and shorts will be squeezed (not soon enough)

JJGl

06/13/19 11:04 AM

Post #12

Feeling a pop coming soon

Roadtojourney Free

06/13/19 9:44 AM

Post #11

Seems like they are still selling imo

Roadtojourney Free

06/13/19 9:21 AM

Post #10

Buying exceeds the selling yet this is down?? Whats going on

T695

06/13/19 7:21 AM

Post #9

The ole switcharooooo

ClayTrader Free

06/11/19 4:44 PM

Post #8

* * $PRVB Video Chart 06-11-2019 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

06/10/19 4:25 PM

Post #7

* * $PRVB Video Chart 06-10-2019 * *

Link to Video - click here to watch the technical chart video

davidsson10 Free

06/10/19 1:16 PM

Post #6

PRVB...

88% Daily gain...

Booked and banked...

$PRVB

Marvy

06/10/19 10:30 AM

Post #5

Wow

Awl416

06/10/19 10:19 AM

Post #4

Retail shorts got roasted ou5 the gates

crudeoil24 PremiumMember

06/10/19 8:07 AM

Post #3

Re: #2: @Dina - Provention Bio announces closing of upsized IPO

Provention Bio shares are trading higher after the company announced study results showing a single course of PRV-031 delayed type 1 diabetes onset in high-risk individuals by at least two years.
Benzinga

Dina

07/24/18 1:37 PM

Post #2

Provention Bio announces closing of upsized IPO

https://seekingalpha.com/article/4189351-daily-pharma-scoop-ipo-review-crinetics-provention-float-ipo-bionano-files

Provention Bio (PRVB) closed its IPO of common shares at $4/share amounting to gross proceeds of ~$63.9M. Shares are expected to start trading on July 24 on The Nasdaq Capital Market. Provention has an extensive and developed pipeline. The pipeline consists of five candidates at various clinical trial stages. The lead candidate is in Phase 3 trial for the interception of Type 1 diabetes (T1D). Two other candidates follow close on its heels and are in mid and advanced Phase 2 trials. Apart from these three, there is one in Phase 1 and another in IND stage.

The lead candidate PRV-031 (teplizumab) is a Phase 3 anti-CD3 monoclonal antibody (‘mAb),. The candidate is being developed for the interception of Type 1 diabetes (‘T1D). The candidate was licensed from MacroGenics, Inc. and has been the put on various earlier clinical studies. The company claims that in these trials involved more than 1,000 subjects with approximately 823 receiving PRV-031 in those trials.

The late pivotal trial of PRV-031 is scheduled to begin in late 2019. That trial will evaluate three potential benefits of PRV-031 in pediatric and adolescent patients. Those three expected benefits under study will be preservation of beta cell function, improvement of glycemic control and decrease in insulin use. According to the American Diabetes Association data in 2015, out of the 30.3 million Americans who had diabetes, ~1.25M American children and adults have type 1 diabetes. Further, 1.5M Americans are apprehended to be diagnosed with diabetes every year. The seventh leading cause.